Market Cap 1.04B
Revenue (ttm) 0.00
Net Income (ttm) -78.31M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 219,300
Avg Vol 856,592
Day's Range N/A - N/A
Shares Out 36.50M
Stochastic %K 64%
Beta 1.68
Analysts Strong Sell
Price Target $51.71

Company Profile

Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders. Its lead product candidate is receptor associated protein (RAP)-219, an investigational small molecule that is designed to inhibit TARPy8-containing AMPARs with picomolar affinity for the treatment of focal epilepsy and other CNS disorders, including periphe...

Industry: Biotechnology
Sector: Healthcare
Phone: 857 321 8020
Address:
1325 Boylston Street, Suite 401, Boston, United States
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 4 at 1:09 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RAPP Current Share Price: $28.54 Contracts: $RAPP May 15, 2026 $30 Calls Scale in: $6.54- $8.00 Scale out: $10.18-$13.09 Can Easily Capture: 60% ROI Blended DTE: 224 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 2 at 10:52 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RAPP Current Share Price: $28.67 Contracts: $RAPP May 15, 2026 $30 Calls Scale in: $6.22- $7.60 Scale out: $9.67-$12.44 Can Easily Capture: 60% ROI Blended DTE: 226 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 1 at 3:04 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RAPP Current Share Price: $29.70 Contracts: $RAPP May 15, 2026 $30 Calls Scale in: $6.40- $7.82 Scale out: $9.95-$12.80 Can Easily Capture: 60% ROI Blended DTE: 226 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
Stonkapedia
Stonkapedia Oct. 1 at 2:19 PM
$RAPP took profits yesterday. I still find this one very compelling and will be watching you, my Boo. ❤️ $QQQ $VOO
0 · Reply
nbkihy8
nbkihy8 Sep. 30 at 10:56 PM
$MBX This will follow a chart like $RAPP
0 · Reply
_www_larval_com_
_www_larval_com_ Sep. 30 at 7:52 PM
$CHOW -8%[11%] $EPSM -6%[-58%] $DLXY -5%[-83%] $RAPP -4%[4%] $DKI 4%[-86%] most notable movement into the final minutes of trading.
0 · Reply
highnihilism
highnihilism Sep. 30 at 11:06 AM
$RAPP Rapport Therapeutics: 38 trades, $27K vs $96K avg (0.28x !!). $25K calls / $2K puts. $IONL Graniteshares 2X Long $IONQ Daily ETF: 43 trades, $192K vs $59K avg (3.28x). $25K calls / $167K puts. $TREX Trex Company: 88 trades, $42K vs $81K avg (0.51x). $25K calls / $17K puts. $TENB Tenable Holdings: 102 trades, $26K vs $27K avg (0.94x). $25K calls / $0.29K puts.
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Sep. 30 at 7:16 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RAPP Current Share Price: $28.02 Contracts: $RAPP May 15, 2026 $30 Calls Scale in: $5.04- $6.16 Scale out: $7.84-$10.08 Can Easily Capture: 60% ROI Blended DTE: 228 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
Stonkapedia
Stonkapedia Sep. 29 at 6:49 PM
$RAPP one little bit of progress with FDA or developments regarding new studies and things will get muy caliente. 🌶️ $QQQ
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Sep. 28 at 4:33 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RAPP Current Share Price: $26.59 Contracts: $RAPP May 15, 2026 $30 Calls Scale in: $4.51- $5.51 Scale out: $7.02-$9.02 Can Easily Capture: 60% ROI Blended DTE: 229 Days | Join Elites here: https://liquidtheta.com
0 · Reply
Latest News on RAPP
Rapport Announces Pricing of Public Offering of Common Stock

Sep 9, 2025, 9:17 PM EDT - 25 days ago

Rapport Announces Pricing of Public Offering of Common Stock


Rapport Announces Proposed Public Offering of Common Stock

Sep 8, 2025, 4:05 PM EDT - 26 days ago

Rapport Announces Proposed Public Offering of Common Stock


Rapport Therapeutics to Host 2025 Investor and Analyst Day

May 21, 2025, 7:00 AM EDT - 4 months ago

Rapport Therapeutics to Host 2025 Investor and Analyst Day


Mise à disposition du rapport financier annuel 2024

Apr 30, 2025, 11:45 AM EDT - 5 months ago

Mise à disposition du rapport financier annuel 2024


Meloni and Trump: An Oval Office Meeting With Rapport and Banter

Apr 18, 2025, 7:46 AM EDT - 6 months ago

Meloni and Trump: An Oval Office Meeting With Rapport and Banter


Rapport semestriel Pilier 3 - 30 juin 2024

Sep 17, 2024, 2:35 AM EDT - 1 year ago

Rapport semestriel Pilier 3 - 30 juin 2024


J&J-backed Rapport Therapeutics raises $136 mln in US IPO

Jun 6, 2024, 7:57 PM EDT - 1 year ago

J&J-backed Rapport Therapeutics raises $136 mln in US IPO

JNJ


Rapport Therapeutics Seeks IPO For CNS Treatment Programs

May 22, 2024, 4:17 PM EDT - 1 year ago

Rapport Therapeutics Seeks IPO For CNS Treatment Programs


LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 4 at 1:09 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RAPP Current Share Price: $28.54 Contracts: $RAPP May 15, 2026 $30 Calls Scale in: $6.54- $8.00 Scale out: $10.18-$13.09 Can Easily Capture: 60% ROI Blended DTE: 224 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 2 at 10:52 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RAPP Current Share Price: $28.67 Contracts: $RAPP May 15, 2026 $30 Calls Scale in: $6.22- $7.60 Scale out: $9.67-$12.44 Can Easily Capture: 60% ROI Blended DTE: 226 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 1 at 3:04 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RAPP Current Share Price: $29.70 Contracts: $RAPP May 15, 2026 $30 Calls Scale in: $6.40- $7.82 Scale out: $9.95-$12.80 Can Easily Capture: 60% ROI Blended DTE: 226 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
Stonkapedia
Stonkapedia Oct. 1 at 2:19 PM
$RAPP took profits yesterday. I still find this one very compelling and will be watching you, my Boo. ❤️ $QQQ $VOO
0 · Reply
nbkihy8
nbkihy8 Sep. 30 at 10:56 PM
$MBX This will follow a chart like $RAPP
0 · Reply
_www_larval_com_
_www_larval_com_ Sep. 30 at 7:52 PM
$CHOW -8%[11%] $EPSM -6%[-58%] $DLXY -5%[-83%] $RAPP -4%[4%] $DKI 4%[-86%] most notable movement into the final minutes of trading.
0 · Reply
highnihilism
highnihilism Sep. 30 at 11:06 AM
$RAPP Rapport Therapeutics: 38 trades, $27K vs $96K avg (0.28x !!). $25K calls / $2K puts. $IONL Graniteshares 2X Long $IONQ Daily ETF: 43 trades, $192K vs $59K avg (3.28x). $25K calls / $167K puts. $TREX Trex Company: 88 trades, $42K vs $81K avg (0.51x). $25K calls / $17K puts. $TENB Tenable Holdings: 102 trades, $26K vs $27K avg (0.94x). $25K calls / $0.29K puts.
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Sep. 30 at 7:16 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RAPP Current Share Price: $28.02 Contracts: $RAPP May 15, 2026 $30 Calls Scale in: $5.04- $6.16 Scale out: $7.84-$10.08 Can Easily Capture: 60% ROI Blended DTE: 228 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
Stonkapedia
Stonkapedia Sep. 29 at 6:49 PM
$RAPP one little bit of progress with FDA or developments regarding new studies and things will get muy caliente. 🌶️ $QQQ
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Sep. 28 at 4:33 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RAPP Current Share Price: $26.59 Contracts: $RAPP May 15, 2026 $30 Calls Scale in: $4.51- $5.51 Scale out: $7.02-$9.02 Can Easily Capture: 60% ROI Blended DTE: 229 Days | Join Elites here: https://liquidtheta.com
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Sep. 27 at 1:21 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RAPP Current Share Price: $24.62 Contracts: $RAPP February 20, 2026 $25 Calls Scale in: $6.66- $8.14 Scale out: $10.36-$13.32 Can Easily Capture: 60% ROI Blended DTE: 147 Days | Join Elites here: https://liquidtheta.com
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Sep. 25 at 2:43 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RAPP Current Share Price: $26.96 Contracts: $RAPP February 20, 2026 $30 Calls Scale in: $3.65- $4.46 Scale out: $5.68-$7.30 Can Easily Capture: 60% ROI Blended DTE: 148 Days | Join Elites here: https://liquidtheta.com
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Sep. 24 at 11:19 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $RAPP Current Share Price: $26.65 Contracts: $RAPP February 20, 2026 $30 Calls Scale in: $3.61- $4.41 Scale out: $5.61-$7.21 Can Easily Capture: 60% ROI Blended DTE: 150 Days | Join Elites here: https://liquidtheta.com
0 · Reply
Stonkapedia
Stonkapedia Sep. 23 at 10:58 PM
$RAPP ima get so hood rich off this one!
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 19 at 3:54 PM
Enter: $RAPP OCT 17 2025 $25 CALLS Buy in Price: $2.20 - $2.20 Take Profit: $2.82 Stop Bleeding: $1.94 ROI Potential: 28% Exit Within: 14 Minutes https://moneygroup.us/alerts
0 · Reply
Stonkapedia
Stonkapedia Sep. 18 at 7:27 PM
$RAPP call be a giant dummy, but I’m pretty happy with my 23.50 average share price. What’s the latest good news? 1) The drug demonstrated a 24% seizure freedom rate and a 77.8% median reduction in clinical seizures in Phase 2a trials, positioning it as a potential best-in-class therapy. 2) RAP-219’s favorable safety profile with a low discontinuation rate may reduce post-marketing safety concerns, enhancing physician and patient acceptance. Next steps? 1) Hold an end-of-phase 2 meeting with the U.S. Food and Drug Administration (FDA) in the fourth quarter of 2025. This is to discuss the phase 2 data and align on the path forward. 2) Initiate an open-label long-term safety trial by the end of 2025, allowing patients from the phase 2a trial to continue treatment with RAP-219. Preliminary results from this safety study are expected in the second half of 2026. 3) Start two Phase 3 pivotal trials of RAP-219 in the third quarter of 2026 for drug-resistant focal onset seizures. $QQQ
1 · Reply
Stonkapedia
Stonkapedia Sep. 17 at 2:07 PM
$RAPP only 434 people watching this?
1 · Reply
Quantumup
Quantumup Sep. 17 at 12:05 PM
Piper Sandler reit'd $PRAX OW-$270: Following vormatrigine's impressive Ph2 RADIANT FOS data, we had the opportunity to catch up with a leading epilepsy expert who treats ~1.5K epilepsy patients (~70% FOS). On the call, the doc highlighted the particular high unmet needs in FOS where ~1/3 of the total population (~3.4M US patients) are resistant to current treatment (he ideally wants next-generation agents providing benefit to comorbidities). Thus, while understanding limitations of open-label RADIANT, our KOL was altogether impressed by the results and looks forward to $PRAX's Ph2/3 POWER program with 12-week POWER1 in 4Q25. Ultimately, the bogey is to show consistent efficacy vs cenobamate. Therefore, the doc will focus on the more stringent endpoint of seizure freedom where he wants to see a response rate of ΔΔ10% as the bogey (any benefit in cenobamate non-responders would also be a win). Therefore, we remain bullish on $PRAX and see substantial upside into a catalyst-rich ~year. $RAPP
0 · Reply
Stonkapedia
Stonkapedia Sep. 16 at 9:57 PM
$RAPP WHO DAT?!
0 · Reply
stockpicker63
stockpicker63 Sep. 16 at 5:51 PM
📈 Trade Alert: $RAPP Current Price: ~$25.92 Suggested Entry: BUY around $25.90 – $26.00 🎯 Price Target & Stop-Loss Target Profit: +30-40% → aiming for ~$33.50 to $36.50 Stop-Loss: approx. −5% → around $24.60
0 · Reply
nbkihy8
nbkihy8 Sep. 16 at 4:25 PM
$RAPP Boom $26
0 · Reply
DavidDayTrade
DavidDayTrade Sep. 16 at 2:13 PM
$RAPP feel like 2nd offering may coming IMO
1 · Reply